Search Results - "Sobolesky, Philip M"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid by Sobolesky, Philip M., Smith, Breland E., Hubbard, Jacqueline A., Stone, Judy, Marcotte, Thomas D., Grelotti, David J., Grant, Igor, Fitzgerald, Robert L.

    Published in Clinica chimica acta (01-04-2019)
    “…A liquid chromatography tandem mass spectrometry method was developed for quantifying ten cannabinoids in oral fluid (OF). This method utilizes OF collected by…”
    Get full text
    Journal Article
  2. 2

    Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancer by Sobolesky, Philip M, Halushka, Perry V, Garrett-Mayer, Elizabeth, Smith, Michael T, Moussa, Omar

    Published in PloS one (01-09-2014)
    “…The transcription factor FOXO3 is a well-established tumor suppressor whose activity, stability, and localization are regulated by phosphorylation and…”
    Get full text
    Journal Article
  3. 3

    Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial by Marcotte, Thomas D, Umlauf, Anya, Grelotti, David J, Sones, Emily G, Sobolesky, Philip M, Smith, Breland E, Hoffman, Melissa A, Hubbard, Jacqueline A, Severson, Joan, Huestis, Marilyn A, Grant, Igor, Fitzgerald, Robert L

    Published in JAMA psychiatry (Chicago, Ill.) (01-03-2022)
    “…Expanding cannabis medicalization and legalization increases the urgency to understand the factors associated with acute driving impairment. To determine, in a…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease by Hou, Wei, Janech, Michael G, Sobolesky, Philip M, Bland, Alison M, Samsuddin, Salma, Alazawi, William, Syn, Wing-Kin

    Published in Bioscience reports (31-01-2020)
    “…Noninvasive biomarkers are clinically useful for evaluating liver fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD). The aim of the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Multicenter assessment of a hemoglobin A1c point-of-care device for diagnosis of diabetes mellitus by Sobolesky, Philip M., Smith, Breland E., Saenger, Amy K., Schulz, Karen, Apple, Fred S., Scott, Mitchell G., Wu, Alan H.B., Little, Randie R., Fitzgerald, Robert L.

    Published in Clinical biochemistry (01-11-2018)
    “…Objective: A multisite investigation compared the analytical performance of a point-of-care (POC) HbA1c device with multiple commonly used HbA1c laboratory…”
    Get full text
    Journal Article
  9. 9

    Feeding a Modified Fish Diet to Bottlenose Dolphins Leads to an Increase in Serum Adiponectin and Sphingolipids by Sobolesky, Philip M, Harrell, Tyler S, Parry, Celeste, Venn-Watson, Stephanie, Janech, Michael G

    Published in Frontiers in endocrinology (Lausanne) (21-04-2016)
    “…Feeding a modified fish diet has been suggested to improve insulin sensitivity in bottlenose dolphins; however, insulin sensitivity was not directly measured…”
    Get full text
    Journal Article
  10. 10

    Interpretation of Pain Management Testing Results Using Case Examples by Sobolesky, Philip M, Smith, Breland E, Pesce, Amadeo J, Fitzgerald, Robert L

    Published in The journal of applied laboratory medicine (01-01-2018)
    “…Because of the increasing volume of opiate-related overdoses, clinical testing of urine for drugs and related compounds in pain management clinics has become…”
    Get full text
    Journal Article
  11. 11

    Abstract 3392: Thromboxane-A2 receptor β-isoform regulates the activity of the tumor suppressor FOXO3 via phosphorylation by ERK in urothelial cancer by Sobolesky, Philip M., Halushka, Perry V., Garrett-Mayer, Elizabeth, Moussa, Omar

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract The tumor suppressor FOXO3 is a transcription factor whose activity and stability are regulated by phosphorylation on S294 via extracellular regulated…”
    Get full text
    Journal Article
  12. 12

    Regulation of the Tumor Suppressor FOXO3 by the Thromboxane-A.sub.2 Receptors in Urothelial Cancer by Sobolesky, Philip M, Halushka, Perry V, Garrett-Mayer, Elizabeth, Smith, Michael T, Moussa, Omar

    Published in PloS one (09-09-2014)
    “…The transcription factor FOXO3 is a well-established tumor suppressor whose activity, stability, and localization are regulated by phosphorylation and…”
    Get full text
    Journal Article
  13. 13

    Abstract 4070: β-arrestin-2 mediated regulation of plasminogen activator inhibitor Type 1 by Sobolesky, Philip M., Zhou, Tanyau, Gorstein, Arielle, Woolworth, Julie A., Moussa, Omar

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Several studies described the elevated levels of plasminogen activated Inhibitor-1 (PAI-1) protein in malignant tissues and indicated the potential…”
    Get full text
    Journal Article
  14. 14

    Regulation of the Tumor Suppressor FOXO3 by the Thromboxane-A2 Receptors in Urothelial Cancer: e107530 by Sobolesky, Philip M, Halushka, Perry V, Garrett-Mayer, Elizabeth, Smith, Michael T, Moussa, Omar

    Published in PloS one (01-09-2014)
    “…The transcription factor FOXO3 is a well-established tumor suppressor whose activity, stability, and localization are regulated by phosphorylation and…”
    Get full text
    Journal Article